(Q73614042)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10744069%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

A possible role of CD46 for the protection in vivo of human renal tumor cells from complement-mediated damage (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10744069%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

V T Blok

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10744069%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

M R Daha

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10744069%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

O M Tijsma

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10744069%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

M G Weissglas

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10744069%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

L J van den Broek

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10744069%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

A Gorter

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10744069%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 March 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10744069%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

published in

Laboratory Investigation

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10744069%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

80

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10744069%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10744069%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

335-344

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10744069%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/labinvest.3780038

5 November 2019

exact match

0 references

cites work

Augmented lung adenocarcinoma cytotoxicity by the combination of a genetically modified anti-Lewis Y antibody and antibodies to complement regulatory proteins

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780038

7 January 2021

Complement-regulatory proteins in ovarian malignancies

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780038

7 January 2021

Renal cell carcinoma--diagnosis and treatment: state of the art.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780038

7 January 2021

Expression of protectin (CD59) in human melanoma and its functional role in cell- and complement-mediated cytotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780038

7 January 2021

Natural history and therapy of metastatic renal cell carcinoma: the role of interleukin-2.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780038

7 January 2021

Phase II trial of interleukin-2 and interferon-alpha in patients with renal cell carcinoma: clinical results and immunologic correlates of response

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780038

7 January 2021

Decay-accelerating factor protects human tumor cells from complement-mediated cytotoxicity in vitro

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780038

7 January 2021

Control of C3b and C5b deposition by CD46 (membrane cofactor protein) after alternative but not classical complement activation

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780038

7 January 2021

Antibodies as cytotoxic therapy

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780038

7 January 2021

Prognostic significance of morphologic parameters in renal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780038

7 January 2021

Immune evasion of tumor cells using membrane-bound complement regulatory proteins

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780038

7 January 2021

Localization of the complement regulatory proteins in the normal human kidney

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780038

7 January 2021

Control of the complement system.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780038

7 January 2021

https://api.crossref.org/works/10.1038%2FLABINVEST.3780038

1 reference

7 January 2021

Identification and characterization of membrane cofactor protein (CD46) in the human kidneys

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780038

7 January 2021

Monoclonal antibody G 250 recognizes a determinant present in renal-cell carcinoma and absent from normal kidney

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780038

7 January 2021

Antibody localization in human renal cell carcinoma: a phase I study of monoclonal antibody G250

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780038

7 January 2021

The management of renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780038

7 January 2021

Quality control of immunohistochemical evaluation of tumour-associated plasminogen activators and related components. European BIOMED-1 Concerted Action on Clinical Relevance of Proteases in Tumour Invasion and Metastasis.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780038

7 January 2021

Targeting of renal cell carcinoma with iodine-131-labeled chimeric monoclonal antibody G250

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780038

7 January 2021

Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC)

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780038

7 January 2021

Expression and distribution of cell-membrane complement regulatory glycoproteins along the human respiratory tract

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780038

7 January 2021

Relative contributions of decay accelerating factor (DAF), membrane cofactor protein (MCP) and CD59 in the protection of melanocytes from homologous complement

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780038

7 January 2021